Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Specialty Drugs (Find 6 items)

Specialty Drugs

Methylcellulose

(9004-67-5)
Thickener & suspending agent in latex paints, paintermediate remover, protective colloid in textile inks, vinyl chloride polymerization, binder, thickener in various building products, water retention agent in various building products, component of adhesives in pasting of hides during tanning, thickener & suspending agent in detergents, hard surface cleaners, additive in foods & pharmaceuticals.

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Methylene blue trihydrate

(7220-79-3)
It is mainly used for dyeing cotton, acrylic fiber, hemp, silk, paper, and also used for the coloring of bamboo and wood and for the production of inks and lakes. It can also be used for the dyeing of biological bacteria; used as redox indicator, adsorption indicator and biological Bacterial stains for staining purposes. Mix indicator for serum protein biochemical test. Prepare exfoliated cell test staining solution. Prepare alkaline methylene blue staining solution. Redox indicator. Determinati

Product List

Request for quotation , get quotes from more suppliers.

Micafungin

(235114-32-6)
Micafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class that was reported in 1999 from Fujisawa in Japan. Unlike other marketed semi-synthetic derivatives in this class, micafungin is not derived from echinocandin but rather from FR901379 which contains a phenolic sulfate to enhance aqueous solubility, a serious limitation in the class. Micafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the cell wall of susceptible fungi and is extensiv

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Specialty drugs refer to medicines that the state has formulated a legal system to implement stricter controls than other medicines. Specialty Drugs of ECHEMI mainly include: ENT drugs, radioisotope drugs, antidote, stomatology drugs, dermatology drugs, surgical treatments and ophthalmic drugs, which mainly supply raw materials for such drugs.

Frequently Asked Questions

What are specialty drugs and how do they differ from traditional medications?

Specialty drugs are high-cost, complex pharmaceuticals used to treat chronic, rare, or difficult-to-manage conditions such as cancer, multiple sclerosis, rheumatoid arthritis, and hepatitis C. Unlike traditional medications, they often require special handling, administration (e.g., injection or infusion), and ongoing patient monitoring. Many are biologics derived from living cells and are subject to stricter regulatory and distribution controls.

Why are specialty drugs so expensive?

Specialty drugs are expensive due to several factors: the high cost of research and development for biologics or orphan drugs, complex manufacturing processes, limited competition (especially for rare diseases), and the need for specialized storage, distribution, and patient support services. Additionally, their targeted nature means they serve smaller patient populations, which impacts pricing strategies to recoup investment.

How are specialty drugs distributed and dispensed?

Specialty drugs are typically distributed through limited-distribution networks, specialty pharmacies, or manufacturer-authorized channels rather than retail pharmacies. They often require temperature-controlled shipping, prior authorization from insurers, and coordination with healthcare providers for proper administration. Patients usually receive these medications with accompanying clinical support, including adherence counseling and side-effect management.

What should healthcare providers consider when prescribing specialty drugs?

Healthcare providers should evaluate the patient’s diagnosis, treatment history, insurance coverage, and ability to adhere to complex regimens before prescribing specialty drugs. They must also consider potential side effects, required monitoring protocols, and whether the drug is covered under the patient’s pharmacy or medical benefit. Coordination with specialty pharmacies and prior authorization processes is often essential to ensure timely access.

How can patients afford specialty drug treatments?

Patients can reduce out-of-pocket costs for specialty drugs through manufacturer copay assistance programs, nonprofit patient assistance foundations, insurance appeals, and therapeutic alternatives approved by their provider. It’s important to work with a specialty pharmacy that offers financial counseling and to verify insurance coverage early in the process. Some government programs like Medicare Part D also provide catastrophic coverage after certain spending thresholds are met.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.